vinay prasad - Search News

News

Vinay Prasad Returns to FDA

Associated Press News on MSN · 4d

Ousted FDA vaccine chief Vinay Prasad is returning to the agency

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top vaccine regulator. Dr.

Dermatology Advisor · 5h

Vinay Prasad Returns to FDA After Being Ousted

Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.

Reuters on MSN · 3d

Vinay Prasad returns to role as top vaccine regulator at FDA days after leaving US agency

Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug Administration a little more than a week after he left the agency. "At the FDA's request,

Vinay Prasad’s return, animal testing alternatives, and mRNA upended

For more on Prasad’s return, go here; for a “Matt’s Take” on Prasad, go here; for the latest on investors’ attitudes toward ...

Science-Based Medicine12hOpinion

Dr. Vinay Prasad’s Catch-22: The Only Way He Can Truly Succeed at His Job is to Get Fired Again

No matter what regulatory decisions Dr. Vinay Prasad makes moving forward, the fact that he was willing to legitimize and ...

6d

Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure

Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...

Fierce Pharma15d

Vinay Prasad's exit signals FDA's probable slip toward more permissive regulation of cell and gene therapy: analyst

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than three months ago.

Science-Based Medicine10dOpinion

Dr. Vinay Prasad’s Legacy is Shattered Trust & 11 Other Thoughts on His Decision to Spend More Time with His Family

Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA. He has our enthusiastic support. Prasad is ...

MedPage Today on MSN2d

Soap Recall Over Sepsis Risk; FDA Rehires Vinay Prasad; NIH Reports Patient to ICE

DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...

Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues

CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...

Pharmaceutical Commerce3d

Pharma Pulse: Vinay Prasad Reinstated as FDA CBER Head, New COVID-19 Risk Data, and the Industry’s Response to Rising Costs

This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results